ALPHA 1 BIOMEDICALS INC
10QSB, EX-27, 2000-11-08
PHARMACEUTICAL PREPARATIONS
Previous: ALPHA 1 BIOMEDICALS INC, 10QSB, 2000-11-08
Next: ALPHA 1 BIOMEDICALS INC, 10QSB, 2000-11-08



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                         542,356
<SECURITIES>                                   963,596
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             1,505,952
<PP&E>                                           3,123
<DEPRECIATION>                                   1,417
<TOTAL-ASSETS>                               1,508,623
<CURRENT-LIABILITIES>                          273,644
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        19,477
<OTHER-SE>                                   1,215,502
<TOTAL-LIABILITY-AND-EQUITY>                 1,508,623
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                               112,672
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                533,409
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            533,409
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                747,028
<CHANGES>                                            0
<NET-INCOME>                                 1,280,437
<EPS-BASIC>                                        .03
<EPS-DILUTED>                                      .05


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission